RYHCX Mutual Fund

RYHCX Mutual Fund

NAV$112.60
See how much of RYHCX you already own
Just $25 once·$99/mo·Download sample
X-ray my portfolio free

Fund Essentials - as of Aug 31, 2026

Net Assets
$187,997.9
Expense Ratio
2.40%
Dividend Yield (Current)
-
Holdings
134
Inception Date
Mar 30, 2001
Fund Family
Rydex Funds
Investment Style
PRO
Asset Class
PRO
Legal Structure
PRO
Dividend Frequency
Annually

Performance

YTD+17.03%
1 Year+23.09%
3 Year+14.88%
5 Year+4.39%
10 Year+9.96%

Asset Allocation

Stocks: 99.14%
Other: 0.86%
See how much of RYHCX you already own
Your funds unpacked, overlap, fees and score, free on screen. The full report comes with FundXLS. Download sample.
X-ray my portfolio free

Top Holdings

View All →
TickerNameWeight
LLYEli Lilly & Co3.86%
JNJJohnson & Johnson - Common3.33%
ABBVAbbvie Inc.2.83%
MRKMerck & Company Inc2.59%
UNHUnitedhealth Group Incorporated2.29%
Top 10 Concentration: 24.42%Report Date: Aug 31, 2026
Download all 134 holdings for RYHCX
CSV export with sector, industry & share changes
Get CSV

Dividend Summary

View Details →
Frequency
Annually
Latest Distribution
$1.41
-

Peer Comparison

Benchmark
PRO
Peer outperformance: PRO
Category rank: PRO
This Mutual Fund
PRO
Peer Avg
PRO

RYHCX Mutual Fund Overview

RYHCX Mutual Fund (Rydex Health Care Fund Class C) is managed by Rydex Funds with $187,997.9 in net assets. RYHCX expense ratio is 2.40%, holding 134 positions across sectors including Health Care, Financials, Information Technology. Inception date: 2001-03-30.

RYHCX performance shows a YTD return of 17.03%. The 1-year return is 23.09% and the 5-year return is 4.39%.

RYHCX top holdings include Eli Lilly & Co (3.9%), Johnson & Johnson - Common (3.3%), Abbvie Inc. (2.8%), Merck & Company Inc (2.6%), Unitedhealth Group Incorporated (2.3%). Go to all RYHCX holdings, RYHCX sectors, or RYHCX dividends.

RYHCX can be compared against other funds. Use RYHCX overlap to find shared positions, or RYHCX vs another fund for a side-by-side view. RYHCX alternatives are available via the screener, along with tax-loss harvesting opportunities.